Orange Book product · Generic (ANDA)
CAPTOPRIL
CAPTOPRIL
At a glance
Mar 28, 1997
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 28, 1997
29 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CAPTOPRIL
Strength
12.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 074532
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CAPTOPRIL
- 1985CAPOTENBrand (NDA)
NDA 018343 · AARXION ANDA HLDING
- 2023CAPTOPRILGeneric (ANDA)
ANDA 214442 · AIPING PHARM INC
- 2019CAPTOPRILGeneric (ANDA)
ANDA 212809 · AJANTA PHARMA LTD
- 2019CAPTOPRILGeneric (ANDA)
ANDA 212223 · SETON PHARMS
- 1998CAPTOPRILGeneric (ANDA)
ANDA 074737 · COREPHARMA
- 1997CAPTOPRILGeneric (ANDA)
ANDA 074677 · ANDAS 5 HOLDING
- 1997CAPTOPRILGeneric (ANDA)
ANDA 074748 · EGIS PHARMS
- 1997CAPTOPRILGeneric (ANDA)
ANDA 074640 · PUREPAC PHARM
- 1996CAPTOPRILGeneric (ANDA)
ANDA 074590 · G AND W LABS INC
- 1996CAPTOPRILGeneric (ANDA)
ANDA 074386 · WATSON LABS
- 1996CAPTOPRILGeneric (ANDA)
ANDA 074576 · WATSON LABS
- 1996CAPTOPRILGeneric (ANDA)
ANDA 074434 · AUROBINDO PHARMA USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
